Cargando…
Therapeutic drug monitoring in a developing nation: a clinical guide
Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advanta...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100237/ https://www.ncbi.nlm.nih.gov/pubmed/25289142 http://dx.doi.org/10.1177/2054270414531121 |
_version_ | 1782326640489005056 |
---|---|
author | Nwobodo, Ndubuisi |
author_facet | Nwobodo, Ndubuisi |
author_sort | Nwobodo, Ndubuisi |
collection | PubMed |
description | Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advantage of rapid turnaround time and ease of operation. The chromatographic methods are specific and cost effective, though more demanding and require technical expertise. The most crucial aspect of any therapeutic drug monitoring service is the expert clinical interpretation of drug concentration measurements taking into consideration individual pharmacokinetic variability in drug disposition across different populations. The setting up of a therapeutic drug monitoring service requires enormous resources, both in terms of equipment and trained personnel. This poses considerable constraints in developing countries due to limited scarce resources, coupled with ignorance among health practitioners on the relevance of therapeutic drug monitoring in clinical practice. Consequently, the need for advocacy, training and encouragement of health practitioners on the usefulness of therapeutic drug monitoring in enhancing patient care and overall clinical outcome in a developing country such as Nigeria can never be over-emphasised. |
format | Online Article Text |
id | pubmed-4100237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-41002372014-10-06 Therapeutic drug monitoring in a developing nation: a clinical guide Nwobodo, Ndubuisi JRSM Open Clinical Review Therapeutic drug monitoring is aimed at using drug concentration measurements to manage a patient’s medication requirement and optimise clinical outcome, particularly in respect of drugs with narrow therapeutic index. Typically, immunoassay methods of various techniques are employed with the advantage of rapid turnaround time and ease of operation. The chromatographic methods are specific and cost effective, though more demanding and require technical expertise. The most crucial aspect of any therapeutic drug monitoring service is the expert clinical interpretation of drug concentration measurements taking into consideration individual pharmacokinetic variability in drug disposition across different populations. The setting up of a therapeutic drug monitoring service requires enormous resources, both in terms of equipment and trained personnel. This poses considerable constraints in developing countries due to limited scarce resources, coupled with ignorance among health practitioners on the relevance of therapeutic drug monitoring in clinical practice. Consequently, the need for advocacy, training and encouragement of health practitioners on the usefulness of therapeutic drug monitoring in enhancing patient care and overall clinical outcome in a developing country such as Nigeria can never be over-emphasised. SAGE Publications 2014-07-08 /pmc/articles/PMC4100237/ /pubmed/25289142 http://dx.doi.org/10.1177/2054270414531121 Text en © The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(http://www.uk.sagepub.com/aboutus/openaccess.htm). |
spellingShingle | Clinical Review Nwobodo, Ndubuisi Therapeutic drug monitoring in a developing nation: a clinical guide |
title | Therapeutic drug monitoring in a developing nation: a clinical guide |
title_full | Therapeutic drug monitoring in a developing nation: a clinical guide |
title_fullStr | Therapeutic drug monitoring in a developing nation: a clinical guide |
title_full_unstemmed | Therapeutic drug monitoring in a developing nation: a clinical guide |
title_short | Therapeutic drug monitoring in a developing nation: a clinical guide |
title_sort | therapeutic drug monitoring in a developing nation: a clinical guide |
topic | Clinical Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100237/ https://www.ncbi.nlm.nih.gov/pubmed/25289142 http://dx.doi.org/10.1177/2054270414531121 |
work_keys_str_mv | AT nwobodondubuisi therapeuticdrugmonitoringinadevelopingnationaclinicalguide |